Showing results (171-180 of 182) with videos related to
Sort By:
Pageof 19
Ophthalmology|November 4, 2004
Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular hole pathology and repairTony H Ko, James G Fujimoto, Jay S Duker, et al.Ophthalmology|August 1, 1996
Optical coherence tomography of age-related macular degeneration and choroidal neovascularizationM R Hee, C R Baumal, C A Puliafito, et al.American Journal of Ophthalmology|September 6, 2016
Quantifying Retinal Microvascular Changes in Uveitis Using Spectral-Domain Optical Coherence Tomography AngiographyAlice Y Kim, Damien C Rodger, Anoush Shahidzadeh, et al.Retina (Philadelphia, Pa.)|October 13, 2006
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusionNinel Z Gregori, Philip J Rosenfeld, Carmen A Puliafito, et al.Plos One|April 25, 2017
Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiographyNicole Koulisis, Alice Y Kim, Zhongdi Chu, et al.Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|September 10, 2008
Calibration of fundus images using spectral domain optical coherence tomographyBrandon J Lujan, Fenghua Wang, Giovanni Gregori, et al.Retina (Philadelphia, Pa.)|June 14, 2006
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRyan M Rich, Philip J Rosenfeld, Carmen A Puliafito, et al.Retina (Philadelphia, Pa.)|May 12, 2009
Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusionNinel Z Gregori, Jaime Gaitan, Philip J Rosenfeld, et al.Retina (Philadelphia, Pa.)|July 9, 2009
Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusionNinel Z Gregori, Ginger Henson Rattan, Philip J Rosenfeld, et al.Retina (Philadelphia, Pa.)|August 22, 2009
Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degenerationKimberly E Stepien, Philip J Rosenfeld, Carmen A Puliafito, et al.Pageof 19